Zheng Liu

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

Organic letters

ACS infectious diseases

Central China Normal University School of Chemistry

City University of New York Graduate School and University Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central China Normal University School of Chemistry May 01 2014

China

Associate Professor

University of Minnesota

United States

Postdoc :: Department of Medicinal Chemistry

Education History

City University of New York Graduate School and University Center

United States

PHD :: Chemistry

Publications

Xing Hu, Mao-Ying Xian, Xi-Feng Wang, Guo-Qing Zou, Rui Luo, Hao Peng, Zheng Liu
Conformationally Restricted Analogues of α-Galactosylceramide as Adjuvant in COVID-19 Subunit Vaccine. ACS medicinal chemistry letters 14 (12) (2023)
Xing Hu, Mao-Ying Xian, Xi-Feng Wang, Guo-Qing Zou, Rui Luo, Hao Peng, Zheng Liu
Conformationally Restricted Analogues of α-Galactosylceramide as Adjuvant in COVID-19 Subunit Vaccine. ACS medicinal chemistry letters 14 (12) (2023)
Ya-Qian Li, Cheng Yan, Xi-Feng Wang, Mao-Ying Xian, Guo-Qing Zou, Xiao-Fei Gao, Rui Luo, Zheng Liu
A New iNKT-Cell Agonist-Adjuvanted SARS-CoV-2 Subunit Vaccine Elicits Robust Neutralizing Antibody Responses. ACS infectious diseases 8 (10) (2022)
Xu-Guang Yin, Jie Lu, Jian Wang, Ru-Yan Zhang, Xi-Feng Wang, Chun-Miao Liao, Xiao-Peng Liu, Zheng Liu, Jun Guo
Synthesis and Evaluation of Liposomal Anti-GM3 Cancer Vaccine Candidates Covalently and Noncovalently Adjuvanted by αGalCer. Journal of medicinal chemistry 64 (4) (2021)
Xi-Feng Wang, Meng-Jia Zhang, Na He, Ya-Cong Wang, Cheng Yan, Xiang-Zhao Chen, Xiao-Fei Gao, Jun Guo, Rui Luo, Zheng Liu
Potent Neutralizing Antibodies Elicited by RBD-Fc-Based COVID-19 Vaccine Candidate Adjuvanted by the Th2-Skewing iNKT Cell Agonist. Journal of medicinal chemistry 64 (15) (2021)
Jing-Jing Du, Shi-Yao Zou, Xiang-Zhao Chen, Wen-Bo Xu, Chang-Wei Wang, Lian Zhang, Yuan-Kai Tang, Shi-Hao Zhou, Jian Wang, Xu-Guang Yin, Xiao-Fei Gao, Zheng Liu, Jun Guo
Liposomal Antitumor Vaccines Targeting Mucin 1 Elicit a Lipid-Dependent Immunodominant Response. Chemistry, an Asian journal 14 (12) (2019)
Xiang-Zhao Chen, Ru-Yan Zhang, Xi-Feng Wang, Xu-Guang Yin, Jian Wang, Ya-Cong Wang, Xiu Liu, Jing-Jing Du, Zheng Liu, Jun Guo
Peptide-free Synthetic Nicotine Vaccine Candidates with α-Galactosylceramide as Adjuvant. Molecular pharmaceutics 16 (4) (2019)
Xu-Guang Yin, Xiang-Zhao Chen, Wen-Mei Sun, Xiao-Shan Geng, Xiao-Kang Zhang, Jian Wang, Pan-Pan Ji, Zhong-Yin Zhou, Dong Jae Baek, Guang-Fu Yang, Zheng Liu, Jun Guo
IgG Antibody Response Elicited by a Fully Synthetic Two-Component Carbohydrate-Based Cancer Vaccine Candidate with α-Galactosylceramide as Built-in Adjuvant. Organic letters 19 (3) (2017)
Xiao-Kang Zhang, Feng Liu, William D Fiers, Wen-Mei Sun, Jun Guo, Zheng Liu, Courtney C Aldrich
Synthesis of Transition-State Inhibitors of Chorismate Utilizing Enzymes from Bromobenzene cis-1,2-Dihydrodiol. The Journal of organic chemistry 82 (7) (2017)

Zheng Liu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zheng Liu